This paper is in the following e-collection/theme issue:

Pharmacovigilance (134) mHealth for Wellness, Behavior Change and Prevention (2871) Mobile Health (mhealth) (2939) Influenza and Influenza-Like-Illness (ILI) Surveillance (217) Infectious Diseases (non-STD/STI) (1575) Vaccination and Immunization in the Digital Age (374) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (156) Surveillance Systems (462) Public (e)Health, Digital Epidemiology and Public Health Informatics (725)

Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/39700, first published .
Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial

Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial

Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial

Authors of this article:

A Brianne Bota1 Author Orcid Image ;   Julie A Bettinger2 Author Orcid Image ;   Shirley Sarfo-Mensah1 Author Orcid Image ;   Jimmy Lopez2 Author Orcid Image ;   David P Smith1 Author Orcid Image ;   Katherine M Atkinson3 Author Orcid Image ;   Cameron Bell4 Author Orcid Image ;   Kim Marty2 Author Orcid Image ;   Mohamed Serhan1 Author Orcid Image ;   David T Zhu1, 5 Author Orcid Image ;   Anne E McCarthy6 Author Orcid Image ;   Kumanan Wilson1, 4, 6, 7 Author Orcid Image
Article Authors Cited by (2) Tweetations (3) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.